Cysto-Conray II is a Ureteral Injection in the Human Prescription Drug category. It is labeled and distributed by Liebel-flarsheim Company Llc. The primary component is Iothalamate Meglumine.
| Product ID | 0019-0862_2245206d-fa19-4898-bfac-71b9340872f4 |
| NDC | 0019-0862 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cysto-Conray II |
| Generic Name | Iothalamate Meglumine |
| Dosage Form | Injection |
| Route of Administration | URETERAL |
| Marketing Start Date | 2010-10-08 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017057 |
| Labeler Name | Liebel-Flarsheim Company LLC |
| Substance Name | IOTHALAMATE MEGLUMINE |
| Active Ingredient Strength | 172 mg/mL |
| Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2010-10-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA017057 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-10-08 |
| Marketing End Date | 2018-10-23 |
| Marketing Category | NDA |
| Application Number | NDA017057 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-10-08 |
| Marketing Category | NDA |
| Application Number | NDA017057 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-10-08 |
| Marketing End Date | 2011-03-17 |
| Ingredient | Strength |
|---|---|
| IOTHALAMATE MEGLUMINE | 172 mg/mL |
| SPL SET ID: | 8841ab4d-674d-4beb-88a5-13e35f6005cc |
| Manufacturer | |
| UNII | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0019-0862 | Cysto-Conray II | Iothalamate meglumine |
| 0019-0953 | Conray | iothalamate meglumine |
| 0019-3183 | Conray 43 | iothalamate meglumine |